Additionally, ATAD2 functions as a co-activator of the estrogen receptor [12] and the androgen receptor [10], implicating it as an oncogenic protein in hormone-related cancers such as breast cancer and prostate cancer. This evidence concerns the gene ATAD2 and breast carcinoma.